CLSI MM06

Quantitative Molecular Methods for Infectious Diseases, 2nd Edition

This document provides guidance for the development and use of quantitative molecular methods, such as nucleic acid probes and nucleic acid amplification techniques of the target sequences specific to particular microorganisms. It also presents recommendations for quality assurance, proficiency testing, and interpretation of results.

This document is available in electronic format only.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of April 2016. The document’s next scheduled review is generally five years after the reaffirmation date.

More Details

Member price:

List Price:

PDF Add to Cart

Details

Chairholder: Angela M. Caliendo, MD, PhD and Helen Fernandes, PhD

Date of Publication: November 30, 2010

Order Code PDF: CLSI MM06A2E
ISBN Number: 1-56238-736-7

Order Code Print: print not available

Edition: Second

Pages: 76

CLSI MM06 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

CLSI MM06 Abstract

Clinical and Laboratory Standards Institute document MM06-A2—Quantitative Molecular Methods for Infectious Diseases; Approved Guideline—Second Edition recognizes the increased use of quantitative molecular methods for determining the concentration of microorganisms in patients. CLSI document MM06 provides guidance for the development and use of quantitative molecular methods, such as nucleic acid probes and nucleic acid amplification techniques of the target sequences specific to particular microorganisms, and presents recommendations for quality assurance, proficiency testing, and interpretation of results.